Literature DB >> 10223504

Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents.

H Engler1, S C Anderson, T R Machemer, J M Philopena, R J Connor, S F Wen, D C Maneval.   

Abstract

OBJECTIVES: Replication deficient adenoviral vectors (rAds) are used as gene delivery systems that can efficiently transduce a variety of tissues and may be appropriate vectors to develop gene therapeutics for many urologic applications. However, the bladder epithelium has been shown to be highly resistant to transgene expression after intracystic administration. A potential explanation for this low gene transfer efficiency may be the protective structure of the urothelium. Since this protective barrier can be disrupted by organic solvents, we assessed whether ethanol co-administration can enhance adenovirus-mediated transgene expression.
METHODS: Normal and bladder tumor-bearing rats received a single intracystic administration of rAd encoding beta-galactosidase (rAd-beta gal) or p53 (rAd-p53). rAd was administered in a saline solution or in solutions with increasing concentrations of ethanol. Transgene expression was evaluated in the bladder tissues.
RESULTS: A dramatic increase in urothelial beta-galactosidase transgene expression was achieved by rAd-beta gal administered in a 22% ethanol solution. Transgene expression was enhanced in normal urothelium and in superficial bladder tumors. p53 transgene expression was similarly enhanced.
CONCLUSIONS: Co-administration of 22% ethanol enhanced local rAd-mediated transgene expression in the normal and neoplastic bladder epithelium in rodents. Improvement of rAd-mediated transgene expression is progress toward local gene delivery to the urothelium and may enable local gene therapy for superficial bladder cancer or other bladder diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223504     DOI: 10.1016/s0090-4295(98)00641-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

Review 1.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

2.  Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury.

Authors:  James I Griffin; Siu Kit Kevin Cheng; Tomoko Hayashi; Dennis Carson; Manju Saraswathy; Devatha P Nair; Dmitri Simberg
Journal:  Nanomedicine       Date:  2017-04-17       Impact factor: 5.307

Review 3.  The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside.

Authors:  Jonathan J Duplisea; Sharada Mokkapati; Devin Plote; Kimberly S Schluns; David J McConkey; Seppo Yla-Herttuala; Nigel R Parker; Colin P Dinney
Journal:  World J Urol       Date:  2018-11-11       Impact factor: 4.226

4.  Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity.

Authors:  Soo-Yeon Kim; Whi-An Kwon; Seung-Pil Shin; Ho Kyung Seo; Soo-Jeong Lim; Yuh-Seog Jung; Hyo-Kyung Han; Kyung-Chae Jeong; Sang-Jin Lee
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation.

Authors:  Chuan Yu; Ofir Stefanson; Yueli Liu; Zhu A Wang
Journal:  J Vis Exp       Date:  2018-05-03       Impact factor: 1.355

Review 6.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

7.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.